albuterol has been researched along with interleukin-8 in 38 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (7.89) | 18.7374 |
| 1990's | 3 (7.89) | 18.2507 |
| 2000's | 25 (65.79) | 29.6817 |
| 2010's | 7 (18.42) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Church, MK; Durham, SR; Holgate, ST; Howarth, PH; Kay, AB; Lee, TH | 1 |
| Bierman, CW | 1 |
| Altounyan, RE; Elliott, EV; Orr, TS; Stern, MA | 1 |
| Kong, L; Li, Z; Yu, R | 1 |
| Au, BT; Collins, PD; Teixeira, MM; Williams, TJ | 1 |
| Holz, O; Jörres, RA; Magnussen, H; Mücke, M; Richter, K | 1 |
| Dent, G; Djukanović, R; Hidi, R; Holgate, ST; Liu, E; Schudt, C; Timmermans, S | 1 |
| Knox, AJ; Pang, L | 1 |
| Ek, A; Larsson, K; Palmberg, L | 1 |
| Farmer, P; Pugin, J | 1 |
| Bellia, V; Bonsignore, G; Bousquet, J; Gagliardo, R; La Grutta, S; Mirabella, F; Pajno, GB; Vignola, AM | 1 |
| Laan, M; Lindén, A; Lötvall, J; Prause, O | 1 |
| Bish, R; Orsida, B; Reid, DW; Walters, EH; Wang, N; Ward, C; Zheng, L | 1 |
| Ho, ST; Hsu, PC; Li, CY; Tsai, CS; Wong, CS; Wu, CT | 1 |
| Cockcroft, DW; Davis, BE; Gordon, JR; Hull, P; Li, F; Swystun, VA; Zhang, X | 1 |
| Corbett, L; Knox, AJ; Nie, M; Pang, L | 1 |
| Bousquet, J; Di Giorgi, R; Gagliardo, R; Gjomarkaj, M; Nicolini, G; Pompeo, F; Profita, M; Vignola, AM | 1 |
| De Backer, WA; Manuel-y-Keenoy, B; Sadowska, AM | 1 |
| Donaldson, GC; Hurst, JR; Müllerova, H; Perera, WR; Sapsford, RJ; Wedzicha, JA; Wilkinson, TM | 1 |
| Pettipher, R; Wettey, FR; Xue, L | 1 |
| Larsson, K; Palmberg, L; Strandberg, K | 1 |
| Folkerts, G; Johnson, M; Karimi, K; Mortaz, E; Nijkamp, FP; Sarir, H | 1 |
| Chung, KF; Issa, R; Johnson, M; Mitchell, J; Oltmanns, U; Sukkar, M; Walters, M; Xie, S | 1 |
| Parker, D; Pavord, I; Rice, L; Woodcock, A | 1 |
| Dorscheid, DR; Greene, CM; MacRedmond, RE; McElvaney, NG; O'Neill, SJ | 1 |
| Aksoy, MO; Ji, R; Kelsen, SG; Li, XX; Reddy, PJ; Yang, Y | 1 |
| Barnes, PJ; Chung, KF; Giembycz, MA; Holden, NS; Kaur, M; Newton, R; Sukkar, MB; Wilson, SM | 1 |
| Folkerts, G; Johnson, M; Mortaz, E; Nijkamp, FP; Raats, D; Rad, MV | 1 |
| Janoff, EN; Kunisaki, KM; Niewoehner, DE; Rector, TS; Rice, KL | 1 |
| Lee, YC; Liu, LY; Perng, DW; Su, KC; Tao, CW; Tsai, CC | 1 |
| Chu, JJ; Fu, LS; Hsu, JY; Weng, YS; Yang, YF | 1 |
| Bell, MJ; Giembycz, MA; Holden, NS; Kaur, M; King, EM; Newton, R; Rider, CF; Salmon, M; Velayudhan, J | 1 |
| Barnes, PJ; Ito, K; Ito, M; Osoata, G; Rossios, C; To, Y | 1 |
| Chen, CS; Chen, YH; Chou, KT; Hsiao, YH; Hsueh, TY; Lee, YC; Perng, DW; Su, KC; Tseng, CM; Wu, YC | 1 |
| Backer, V; Bangsbo, J; Hostrup, M; Kalsen, A | 1 |
| Abraham, G; Mittag, A; Nieber, K; Oehme, S; Schrödl, W; Tarnok, A | 1 |
| Ambrus, DB; Bajwa, EK; Benjamin, EJ; Hibbert, KA; Walkey, AJ | 1 |
| Bonta, PI; Chowdhury, S; Dijkhuis, A; Lutter, R; Ravi, A; Sterk, PJ | 1 |
8 trial(s) available for albuterol and interleukin-8
| Article | Year |
|---|---|
Influence of albuterol, cromolyn sodium and ipratropium bromide on the airway and circulating mediator responses to allergen bronchial provocation in asthma.
Topics: Adult; Albuterol; Asthma; Atropine Derivatives; Bronchial Provocation Tests; Chemotactic Factors; Cromolyn Sodium; Female; Forced Expiratory Volume; Histamine; Humans; Interleukin-8; Ipratropium; Male; Middle Aged; Respiratory System | 1985 |
Influence of fluticasone and salmeterol on airway effects of inhaled organic dust;an in vivo and ex vivo study.
Topics: Adrenergic beta-Agonists; Adult; Albuterol; Allergens; Androstadienes; Animals; Anti-Asthmatic Agents; Anti-Inflammatory Agents; Bronchoalveolar Lavage Fluid; Cells, Cultured; Dust; Fluticasone; Humans; Inhalation Exposure; Interleukin-6; Interleukin-8; Macrophages, Alveolar; Male; Middle Aged; Salmeterol Xinafoate; Swine; Tumor Necrosis Factor-alpha | 2000 |
Possible anti-inflammatory effect of salmeterol against interleukin-8 and neutrophil activation in asthma in vivo.
Topics: Adrenergic beta-Agonists; Adult; Aged; Albuterol; Anti-Inflammatory Agents; Asthma; Bronchoalveolar Lavage Fluid; Bronchoscopy; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Interleukin-8; Male; Middle Aged; Neutrophil Activation; Peroxidase; Salmeterol Xinafoate; Time Factors | 2003 |
Regular salbutamol use increases CXCL8 responses in asthma: relationship to the eosinophil response.
Topics: Adult; Albuterol; Analysis of Variance; Asthma; Bronchial Provocation Tests; Bronchodilator Agents; Chemokines, CXC; Cross-Over Studies; Double-Blind Method; Enzyme-Linked Immunosorbent Assay; Eosinophils; Female; Humans; Immunohistochemistry; Inflammation Mediators; Interleukin-8; Male; Middle Aged; Sputum; Statistics, Nonparametric; Up-Regulation | 2003 |
Salmeterol plus fluticasone propionate versus fluticasone propionate plus montelukast: a randomised controlled trial investigating the effects on airway inflammation in asthma.
Topics: Acetates; Adrenergic beta-Agonists; Adult; Albuterol; Androstadienes; Anti-Asthmatic Agents; Asthma; Bronchial Hyperreactivity; Cyclopropanes; Cysteine; Double-Blind Method; Drug Combinations; Female; Fluticasone; Fluticasone-Salmeterol Drug Combination; Forced Expiratory Volume; Histamine; Humans; Interleukin-8; Leukotriene Antagonists; Leukotrienes; Lung; Male; Quinolines; Spirometry; Sputum; Sulfides; Time Factors; Treatment Outcome; United Kingdom | 2007 |
Exhaled nitric oxide, systemic inflammation, and the spirometric response to inhaled fluticasone propionate in severe chronic obstructive pulmonary disease: a prospective study.
Topics: Administration, Inhalation; Aged; Albuterol; Androstadienes; Biomarkers; Bronchodilator Agents; C-Reactive Protein; Female; Fluticasone; Forced Expiratory Volume; Humans; Inflammation; Interleukin-6; Interleukin-8; Male; Nitric Oxide; Prospective Studies; Pulmonary Disease, Chronic Obstructive; ROC Curve; Salmeterol Xinafoate; Severity of Illness Index; Spirometry | 2008 |
Anti-inflammatory effects of salmeterol/fluticasone, tiotropium/fluticasone or tiotropium in COPD.
Topics: Administration, Inhalation; Adult; Aged; Aged, 80 and over; Albuterol; Androstadienes; Biomarkers; C-Reactive Protein; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Female; Fluticasone; Humans; Inflammation; Interleukin-8; Male; Matrix Metalloproteinase 9; Middle Aged; Pulmonary Disease, Chronic Obstructive; Respiratory Function Tests; Salmeterol Xinafoate; Scopolamine Derivatives; Sputum; Tiotropium Bromide | 2009 |
Combined inhalation of beta2 -agonists improves swim ergometer sprint performance but not high-intensity swim performance.
Topics: Administration, Inhalation; Adolescent; Adrenergic beta-2 Receptor Agonists; Albuterol; Athletic Performance; Cross-Over Studies; Double-Blind Method; Ethanolamines; Female; Formoterol Fumarate; Humans; Interleukin-6; Interleukin-8; Isometric Contraction; Male; Muscle Strength; Physical Endurance; Quadriceps Muscle; Salmeterol Xinafoate; Swimming | 2014 |
30 other study(ies) available for albuterol and interleukin-8
| Article | Year |
|---|---|
A comparison of late reactions to antigen and exercise.
Topics: Albuterol; Antigens; Asthma; Asthma, Exercise-Induced; Bronchial Provocation Tests; Chemotactic Factors; Cromolyn Sodium; Forced Expiratory Volume; Histamine Release; Humans; Hypersensitivity, Delayed; Hypersensitivity, Immediate; Interleukin-8; Mast Cells; Methacholine Chloride; Methacholine Compounds; Respiratory Hypersensitivity; Skin Tests; Theophylline | 1984 |
Modulation of release of neutrophil chemotactic factor (NCF).
Topics: Albuterol; Antigens; Bronchial Spasm; Chemotactic Factors; Chemotaxis, Leukocyte; Cromolyn Sodium; Cytoplasmic Granules; Dose-Response Relationship, Drug; Forced Expiratory Volume; Humans; Interleukin-8; Mast Cells; Neutrophils; Sulfur Dioxide | 1980 |
[The effect of salmeterol on the activity of neutrophil chemotactic factor in patients with asthma].
Topics: Adrenergic beta-Agonists; Adult; Albuterol; Asthma; Female; Humans; Interleukin-8; Male; Middle Aged; Procaterol; Respiratory Function Tests; Salmeterol Xinafoate | 1996 |
Effect of PDE4 inhibitors on zymosan-induced IL-8 release from human neutrophils: synergism with prostanoids and salbutamol.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adult; Albuterol; Benzamides; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclohexanecarboxylic Acids; Drug Synergism; Humans; Interleukin-8; Neutrophils; Nitriles; Phosphodiesterase Inhibitors; Prostaglandins; Pyridines; Pyrrolidinones; Rolipram; Zymosan | 1998 |
Sequentially induced sputum in patients with asthma or chronic obstructive pulmonary disease.
Topics: Administration, Inhalation; Administration, Oral; Adrenergic beta-Agonists; Adult; Aged; Albuterol; Asthma; Blood Proteins; Eosinophil Granule Proteins; Eosinophils; Female; Glucocorticoids; Humans; Interleukin-8; Lung Diseases, Obstructive; Male; Middle Aged; Prednisolone; Respiratory Function Tests; Ribonucleases; Sputum | 1999 |
Phosphodiesterase and cyclic adenosine monophosphate-dependent inhibition of T-lymphocyte chemotaxis.
Topics: Albuterol; Asthma; Bucladesine; Chemotaxis, Leukocyte; Colforsin; Cyclic AMP; Humans; Interleukin-8; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Platelet Activating Factor; Rolipram; T-Lymphocytes; Theophylline | 2000 |
Synergistic inhibition by beta(2)-agonists and corticosteroids on tumor necrosis factor-alpha-induced interleukin-8 release from cultured human airway smooth-muscle cells.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Adrenal Cortex Hormones; Adrenergic beta-2 Receptor Antagonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Albuterol; Androstadienes; Asthma; Cell Survival; Cells, Cultured; Colforsin; Cyclic AMP-Dependent Protein Kinases; Dexamethasone; Drug Synergism; Fluticasone; Humans; Interleukin-8; Muscle, Smooth; Phosphodiesterase Inhibitors; Propanolamines; Receptors, Adrenergic, beta-2; Respiratory System; Rolipram; Salmeterol Xinafoate; Trachea; Tumor Necrosis Factor-alpha | 2000 |
beta-adrenergic agonists exert their "anti-inflammatory" effects in monocytic cells through the IkappaB/NF-kappaB pathway.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Albuterol; Anti-Inflammatory Agents, Non-Steroidal; Bucladesine; Cell Line; Cell Nucleus; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Dinoprostone; DNA-Binding Proteins; Enzyme Activation; Epinephrine; Fenoterol; Gene Expression Regulation; Humans; I-kappa B Proteins; Iloprost; Interleukin-8; Isoproterenol; Kinetics; Lipopolysaccharide Receptors; Lipopolysaccharides; Monocytes; NF-kappa B; NF-KappaB Inhibitor alpha; Norepinephrine; Tumor Necrosis Factor-alpha | 2000 |
Clinical and biological heterogeneity in children with moderate asthma.
Topics: Adolescent; Albuterol; Androstadienes; Anti-Inflammatory Agents; Asthma; Biomarkers; Bronchodilator Agents; Calcium-Binding Proteins; Child; Female; Fluticasone; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Interleukin-8; Leukocytes, Mononuclear; Male; Membrane Glycoproteins; Nerve Tissue Proteins; NF-kappa B; Nitric Oxide; Receptors, Cell Surface; Salmeterol Xinafoate; Synaptotagmin I; Synaptotagmins | 2003 |
Pharmacological modulation of interleukin-17-induced GCP-2-, GRO-alpha- and interleukin-8 release in human bronchial epithelial cells.
Topics: Adrenergic beta-Agonists; Albuterol; ATP Binding Cassette Transporter, Subfamily B, Member 1; Bronchi; Calcineurin Inhibitors; Calcium-Calmodulin-Dependent Protein Kinases; Cell Line, Transformed; Chemokine CXCL1; Chemokine CXCL6; Chemokines; Chemokines, CXC; Chemotactic Factors; Cyclosporine; Dose-Response Relationship, Drug; Enzyme Inhibitors; Epithelial Cells; Flavonoids; Humans; Hydrocortisone; Imidazoles; Intercellular Signaling Peptides and Proteins; Interleukin-17; Interleukin-8; Mitogen-Activated Protein Kinases; p38 Mitogen-Activated Protein Kinases; Pyridines; Receptors, Adrenergic, beta; Receptors, Glucocorticoid | 2003 |
Dobutamine modulates lipopolysaccharide-induced macrophage inflammatory protein-1alpha and interleukin-8 production in human monocytes.
Topics: Adrenergic beta-Agonists; Albuterol; Cell Line; Cell Movement; Chemokine CCL3; Chemokine CCL4; Chemotaxis; Depression, Chemical; Dobutamine; Humans; In Vitro Techniques; Interleukin-8; Lipopolysaccharides; Macrophage Inflammatory Proteins; Monocytes; Reverse Transcriptase Polymerase Chain Reaction | 2003 |
Differential regulation of chemokine expression by peroxisome proliferator-activated receptor gamma agonists: interactions with glucocorticoids and beta2-agonists.
Topics: Adrenergic beta-Agonists; Albuterol; Androstadienes; Blotting, Western; Cell Line; Chemokine CCL11; Chemokine CCL2; Chemokines; Chemokines, CC; Chromans; Chromatin; Chromatin Immunoprecipitation; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Fluticasone; Gene Expression Regulation; Glucocorticoids; Humans; Immunoprecipitation; Interleukin-8; Plasmids; PPAR alpha; PPAR gamma; Promoter Regions, Genetic; Prostaglandin D2; Protein Binding; Pyrimidines; Receptors, Glucocorticoid; Reverse Transcriptase Polymerase Chain Reaction; RNA; Salmeterol Xinafoate; Thiazolidinediones; Transcription, Genetic; Transfection; Troglitazone; Tumor Necrosis Factor-alpha | 2005 |
Biochemical interaction between effects of beclomethasone dipropionate and salbutamol or formoterol in sputum cells from mild to moderate asthmatics.
Topics: Adult; Albuterol; Anti-Asthmatic Agents; Asthma; Beclomethasone; Bronchodilator Agents; Cells, Cultured; Chemokine CCL5; Drug Interactions; Drug Therapy, Combination; Ethanolamines; Female; Formoterol Fumarate; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Interleukin-8; Male; Middle Aged; Receptors, Adrenergic, beta-2; Receptors, Glucocorticoid; Severity of Illness Index; Sputum; Tissue Distribution | 2005 |
Inhibition of in vitro neutrophil migration through a bilayer of endothelial and epithelial cells using beta2-agonists: concomitant effects on IL-8 and elastase secretion and impact of glucocorticosteroids.
Topics: Adrenergic beta-Agonists; Albuterol; Anti-Inflammatory Agents; Bronchodilator Agents; Budesonide; Dose-Response Relationship, Drug; Drug Therapy, Combination; Epithelial Cells; Humans; Interleukin-8; Neutrophil Infiltration; Neutrophils; Pancreatic Elastase; Pulmonary Disease, Chronic Obstructive | 2005 |
Inflammatory changes, recovery and recurrence at COPD exacerbation.
Topics: Administration, Inhalation; Adrenergic beta-Agonists; Aged; Albuterol; Biomarkers; C-Reactive Protein; Cohort Studies; Disease Progression; Female; Follow-Up Studies; Forced Expiratory Volume; Humans; Inflammation Mediators; Interleukin-6; Interleukin-8; London; Male; Middle Aged; Peak Expiratory Flow Rate; Prognosis; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Recurrence; Sputum | 2007 |
Salbutamol inhibits trypsin-mediated production of CXCL8 by keratinocytes.
Topics: Adenylyl Cyclases; Albuterol; Cells, Cultured; Colforsin; Cyclic AMP; Dideoxyadenosine; Humans; Interleukin-8; Keratinocytes; Rolipram; Trypsin | 2006 |
Effect of formoterol and salmeterol on IL-6 and IL-8 release in airway epithelial cells.
Topics: Adrenergic beta-Agonists; Albuterol; Animals; Bronchi; Bronchodilator Agents; Cells, Cultured; Dose-Response Relationship, Immunologic; Dust; Epithelial Cells; Ethanolamines; Formoterol Fumarate; Humans; Interleukin-6; Interleukin-8; Respiratory Mucosa; Salmeterol Xinafoate; Swine; Tumor Cells, Cultured | 2007 |
Combination of fluticasone propionate and salmeterol potentiates the suppression of cigarette smoke-induced IL-8 production by macrophages.
Topics: Adrenergic beta-Agonists; Albuterol; Androstadienes; Cells, Cultured; Dose-Response Relationship, Drug; Drug Synergism; Fluticasone; Humans; Interleukin-8; Macrophages; Monocytes; Nicotiana; Salmeterol Xinafoate; Smoke; Time Factors | 2007 |
Fluticasone, but not salmeterol, reduces cigarette smoke-induced production of interleukin-8 in human airway smooth muscle.
Topics: Adrenergic beta-Agonists; Albuterol; Androstadienes; Bronchi; Cells, Cultured; Dose-Response Relationship, Drug; Fluticasone; Glucocorticoids; Humans; Interleukin-8; Muscle, Smooth; Nicotiana; Salmeterol Xinafoate; Smoke; Tumor Necrosis Factor-alpha | 2008 |
Epithelial expression of TLR4 is modulated in COPD and by steroids, salmeterol and cigarette smoke.
Topics: Adrenal Cortex Hormones; Adrenergic beta-Agonists; Adult; Aged; Albuterol; Androstadienes; beta-Defensins; Case-Control Studies; Cell Line; Dexamethasone; Dose-Response Relationship, Drug; Drug Interactions; Female; Fluticasone; Gene Expression Regulation; Humans; Interleukin-8; Lipopolysaccharides; Male; Middle Aged; Nasal Mucosa; Pulmonary Disease, Chronic Obstructive; Respiratory Mucosa; RNA, Messenger; Salmeterol Xinafoate; Severity of Illness Index; Smoke; Smoking; Toll-Like Receptor 4 | 2007 |
Inhibition by salmeterol and cilomilast of fluticasone-enhanced IP-10 release in airway epithelial cells.
Topics: Adrenergic beta-Agonists; Albuterol; Asthma; Carboxylic Acids; Cells, Cultured; Chemokine CXCL10; Cyclohexanecarboxylic Acids; Enzyme-Linked Immunosorbent Assay; Epithelial Cells; Gene Expression; Humans; Interleukin-8; Nitriles; Phosphodiesterase Inhibitors; Respiratory Mucosa; Reverse Transcriptase Polymerase Chain Reaction; RNA; Salmeterol Xinafoate | 2008 |
Effect of beta2-adrenoceptor agonists and other cAMP-elevating agents on inflammatory gene expression in human ASM cells: a role for protein kinase A.
Topics: Adrenergic beta-2 Receptor Agonists; Albuterol; Cells, Cultured; Colforsin; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Dinoprostone; Gene Expression; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Inflammation Mediators; Intercellular Adhesion Molecule-1; Interleukin-6; Interleukin-8; Myocytes, Smooth Muscle; Respiratory System; Salmeterol Xinafoate | 2008 |
Salmeterol with fluticasone enhances the suppression of IL-8 release and increases the translocation of glucocorticoid receptor by human neutrophils stimulated with cigarette smoke.
Topics: Adrenergic beta-Agonists; Albuterol; Androstadienes; Animals; Bronchodilator Agents; Dual Specificity Phosphatase 1; Fluticasone; Humans; Interleukin-8; Matrix Metalloproteinases; Mitogen-Activated Protein Kinases; Neutrophils; NF-kappa B; Nicotiana; Pancreatic Elastase; Pulmonary Disease, Chronic Obstructive; Reactive Oxygen Species; Receptors, Glucocorticoid; Receptors, Interleukin-8A; Receptors, Interleukin-8B; Salmeterol Xinafoate; Signal Transduction; Smoke | 2008 |
Asthma drugs counter-regulate interleukin-8 release stimulated by sodium sulfite in an A549 cell line.
Topics: Acetates; Air Pollutants; Albuterol; Androstadienes; Anti-Asthmatic Agents; Cell Line; Cell Survival; Cyclopropanes; Dose-Response Relationship, Drug; Epithelial Cells; Fluticasone; Humans; Inflammation; Interleukin-8; Lung; Quinolines; Salmeterol Xinafoate; Signal Transduction; Sulfides; Sulfites | 2009 |
Enhancement of inflammatory mediator release by beta(2)-adrenoceptor agonists in airway epithelial cells is reversed by glucocorticoid action.
Topics: Adrenergic beta-2 Receptor Agonists; Adrenergic beta-Agonists; Albuterol; Asthma; Bronchi; Bronchodilator Agents; Cell Line; Dexamethasone; Epithelial Cells; Ethanolamines; Formoterol Fumarate; Gene Expression Regulation; Glucocorticoids; Humans; Inflammation Mediators; Interleukin-6; Interleukin-8; Salmeterol Xinafoate; Transcription, Genetic | 2010 |
Corticosteroid insensitivity is reversed by formoterol via phosphoinositide-3-kinase inhibition.
Topics: 1-Phosphatidylinositol 4-Kinase; Adenine; Adrenal Cortex Hormones; Adrenergic beta-2 Receptor Agonists; Adult; Aged; Albuterol; Androstadienes; Asthma; Budesonide; Chromones; Dexamethasone; Drug Resistance; Ethanolamines; Female; Fluticasone; Formoterol Fumarate; Humans; Hydrogen Peroxide; Interleukin-8; Leukocytes, Mononuclear; Male; Middle Aged; Morpholines; Oxidative Stress; Pulmonary Disease, Chronic Obstructive; Quinazolines; Receptors, Adrenergic, beta-2; Salmeterol Xinafoate; U937 Cells; Young Adult | 2012 |
Long-acting β2 agonists and corticosteroids restore the reduction of histone deacetylase activity and inhibit H2O2-induced mediator release from alveolar macrophages.
Topics: Adrenergic beta-2 Receptor Agonists; Aged; Aged, 80 and over; Albuterol; Androstadienes; Anti-Inflammatory Agents; Budesonide; Dose-Response Relationship, Drug; Ethanolamines; Female; Fluticasone; Formoterol Fumarate; Glucocorticoids; Histone Deacetylases; Humans; Hydrogen Peroxide; Interleukin-8; Macrophages, Alveolar; Male; Matrix Metalloproteinase 9; Middle Aged; Oxidants; RNA, Messenger; Salmeterol Xinafoate | 2012 |
Agonist-induced β2-adrenoceptor desensitization and downregulation enhance pro-inflammatory cytokine release in human bronchial epithelial cells.
Topics: Adrenergic beta-2 Receptor Agonists; Adrenergic beta-Antagonists; Albuterol; Bronchi; Cells, Cultured; Cyclic AMP; Cytokines; Dose-Response Relationship, Drug; Down-Regulation; Epithelial Cells; Humans; Inflammation Mediators; Interleukin-6; Interleukin-8; Isoproterenol; Propanolamines; Propranolol; Receptors, Adrenergic, beta-2; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Time Factors | 2015 |
Risk factors and outcomes associated with new-onset atrial fibrillation during acute respiratory distress syndrome.
Topics: Aged; Albuterol; Atrial Fibrillation; Biomarkers; Bronchodilator Agents; Female; Hospital Mortality; Humans; Interleukin-6; Interleukin-8; Male; Middle Aged; Odds Ratio; Prognosis; Prospective Studies; Respiratory Distress Syndrome; Risk Factors | 2015 |
Neutrophilic inflammation in asthma and defective epithelial translational control.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aged; Albuterol; Asthma; Bronchi; Bronchial Hyperreactivity; Bronchoalveolar Lavage; Cell Line, Tumor; Cytoplasm; Epithelial Cells; Epithelium; Female; Forced Expiratory Volume; Humans; Inflammation; Interleukin-17; Interleukin-8; Lung; Male; Methacholine Chloride; Middle Aged; Neutrophils; Randomized Controlled Trials as Topic; Respiratory Function Tests; Smoking; Tumor Necrosis Factor-alpha; Young Adult | 2019 |